BITS & IBGRL PUBLICATIONS 2003 IBGRL-publica70.gif (2837 bytes)
 

 

IBGRL-publica40.gif (1679 bytes)    RETURN TO PUBLICATIONS HOME PAGE

 

 

Books and Book Chapters

Daniels G, Hadley A. Blood groups on red cells, platelets, and neutrophils. In: Wickramasinghe SN, McCullough J, eds. Blood and Bone Marrow Pathology. Edinburgh: Elsevier Science, 2003:615-635.

Daniels G. The molecular basis for human blood group polymorphism. In: Aluja MP, Malgosa A, Nogués M, eds. Antropologia y Biodiversidad. Barcelona: Edicions Bellaterra, 2003.

Daniels G. Immunohematology of the Kell and Kx blood group systems. In: Danek A, ed. Neuroacanthocytosis Syndromes: New Perspectives for the Study of Basal Ganglia Degenerations. Kluwer Academic Publishers: Dordrecht. In press.

Review Articles, Editorials and Letters 

Blair A, Pamphilon DH. Leukaemic stem cells. Transfus Med. 2003 Dec;13(6):363-75.

Daniels GL, Hadley A, Green CA Causes of fetal anemia in hemolytic disease due to anti-K Transfusion (2003) 43: 115-6

Finning K, Daniels G, Martin P, Soothill P. Detection of fetal Rhesus D gene in whole blood of women booking for routine antenatal care [Eur J Obstet Gynecol Reprod Biol 2003;108:29-32]. Eur J Obstet Gynecol Reprod Biol. 2003 Sep 10;110(1):117; author reply 118.

Pamphilon DH, Lowdell MW. Stem cells and Immunotherapy. Transfus Med. 2003 Dec;13(6):323-4.

Original Articles

Arriaga F, Mueller A, Rodberg K, Ciesielski D, Poole J, Banks J, De La Rubia J, Carpio N, Marty ML, Garratty G. A new antigen of the Er collection. Vox Sang. 2003 Feb;84(2):137-9.

Bartha JL, Finning K, Soothill PW Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency. Obstet Gynecol. 2003 May;101(5 Pt 2):1135-6.

Bakacs T, Szabo M, Varga L, Mushens R, Mehrishi JN, Lutz HU,  Merry AH and Tusnady G. Micromolar A and B Blood Group Active Trisaccharides Abolish Human Complement Haemolytic Activity Assayed by Erythrocytes.  Int Arch Allergy Immunol 2003; 130: 236-246

Beringue V, Mallinson G, Kaisar M, Tayebi M, Sattar Z, Jackson G, Anstee D, Collinge J, Hawke S. Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain. 2003 Jun 23; 126:

Bruce LJ, Beckmann R, Ribeiro ML, Peters LL, Chasis JA, Delaunay J, Mohandas N, Anstee DJ, Tanner MJ. A band 3-based macrocomplex of integral and peripheral proteins in the RBC membrane. Blood. 2003 May 15;101(10):4180-4188.

Chakrabarti S, Brown J, Guttridge M, Pamphilon DH, Lankester A, Marks DI. Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback. Bone Marrow Transplant. 2003 Jul;32(1):23-30. 

Crew VK, Green CA, Daniels GL. Molecular bases of the antigens of the Lutheran blood group system. Transfusion 2003;43:1729-1737.

Gilbert RL, Rider JR, Turton JR, Pamphilon DH. Detection of residual donor leucocytes in leucoreduced red blood cell components using a fluorescence microplate assay. J Immunol Methods. 2003 Mar 1;274(1-2):17-25.

Hellberg A, Steffensen R, Yahalom V, Sojka BN, Heier HE, Levene C, Poole J,
Olsson ML.  Additional molecular bases of the clinically important p blood group phenotype.
Transfusion. 2003 Jul;43(7):899-907.

Kerr JP, Liakopolou E, Brown J, Cornish JM, Fleming D, Massey E, Oakhill A, Pamphilon DH, Robinson SP, Totem A, Valencia AM, Marks DI. The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation. Br J Haematol. 2003 Oct;123(1):114-8. 

Kumpel BM, MacDonald AP. Quantitation and phenotyping of fetal RBCs in maternal blood by flow cytometry. Transfusion. 2003 Mar;43(3):416-7.

Kumpel BM, De Haas M, Koene HR, Van De Winkel JG, Goodrick MJ. Clearance of red cells by monoclonal IgG3 anti-D in vivo is affected by the VF polymorphism of Fcgamma RIIIa (CD16). Clin Exp Immunol. 2003 Apr;132(1):81-6.

Lee G, Spring FA, Parsons SF, Mankelow TJ, Peters LL, Koury MJ, Mohandas N, Anstee DJ, Chasis JA. Novel secreted isoform of adhesion molecule ICAM-4: potential regulator of membrane-associated ICAM-4 interactions. Blood. 2003 Mar 1;101(5):1790-7.

van Rhenen D, Gulliksson H, Cazenave JP, Pamphilon D, Ljungman P, Kluter H, Vermeij H, Kappers-Klunne M, de Greef G, Laforet M, Lioure B, Davis K, Marblie S, Mayaudon V, Flament J, Conlan M, Lin L, Metzel P, Buchholz D, Corash L; euroSPRITE trial. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood. 2003 Mar 15;101(6):2426-33.

Singleton BK, Green CA, Renaud S, Fuhr P, Poole J, Daniels GL. McLeod syndrome resulting from a novel XK mutation. Br J Haematol. 2003 Aug;122(4):682-5 

Wagner FF, Poole J, Flegel WA. Scianna antigens including Rd are expressed by ERMAP. Blood. 2003 Jan 15;101(2):752-7

White AR, Enever P, Tayebi M, Mushens R, Linehan J, Brandner S, Anstee D, Collinge J, Hawke S. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature. 2003 Mar 6;422(6927):80-3.

Guidelines and Workshop Reports

Daniels GL, Cartron JP, Fletcher A, Garratty G, Henry S, Jorgensen J, Judd WJ, Levene C, Lin M, Lomas-Francis C, Moulds JJ, Moulds JM, Moulds M, Overbeeke M, Reid ME, Rouger P, Scott M, Sistonen P, Smart E, Tani Y, Wendel S, Zelinski T. International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Vancouver Report. Vox Sang. 2003 Apr;84(3):244-7

Published Abstracts

Anstee DJ. Life and the Red Cell. Transfusion Medicine 13 supp. 1, A2 (2003)

Arndt PA, Green C, Wilkes A, Peterson D, Daniels G, Garratty G. Hemolytic Disease of the Newborn Due to Anti-Ge and Further Evidence for Destruction of Precursor Erythroid Cells Transfusion 43 Supplement; 98A 2003

Blair A, Cox CV, Goulden NJ, Oakhill A, Pamphilon DH, Evely RS. A primitive cell origin for Acute Lymphoblastic Leukaemia. Blood 102; 369, 2003.

Cox CV, Goulden NJ, Oakhill A, Evely RS, Pamphilon DH, Blair A. Characterisation and purification of ALL progenitor cells. Experimental Hematology 31; 82, 2003.

Cox CV, Goulden NJ, Oakhill A, Pamphilon DH, Blair A. Proliferation of ALL blasts in long term culture. Experimental Hematology 31; 150, 2003.

Cox CV, Evely RS, Oakhill A, Goulden NJ, Pamphilon DH, Blair A. Immunophenotypic characterisation of T-ALL progenitor cells. Blood 102; 369, 2003.

Finning K, Martin P and Daniels G. Fetal RHD Genotyping Using Free Fetal DNA in Maternal Plasma: An Update Transfusion Medicine 13 supp. 1, O8 (2003)

Grey D, Poole J, Martin P, Condon J, Allwright J, O’Day S, Daniels G. Haemolytic Disease of the Newborn caused by a new Kell antigen. Transfusion Medicine 13 supp. 1, P23 (2003).

Irwin K, Melanaphy R, Warke N, Nascimento, Banks J, Martin P, Chabert T, Rodrigues MJ, Morris K, Poole J. A new Rhnull blood donor and the International Rare Donor Panel. Transfusion Medicine 13 supp. 1, P25 (2003).

Karamatic Crew V, Daniels G, Poole J. A new variant in Ok blood group system. Transfusion medicine 13 supp. 1, P32 (2003).

Karamatic Crew V, Green CA, Daniels G, Anstee DJ. Renal failure associated with an inactivating mutation in the human CD151 gene of three individuals lacking the MER2 blood group. Blood 2003;102:4a.

King M-J, Chapman L, Mackinnon H, Mills W, Psiachou-Leonard E and Murrin R. Examination of flow cytometric histograms of eosin-5-maleimide labelled red cells can assist in differential diagnosis of membranopathy. Br J Haematology vol. 121, Supplement 1, p75 (abstract #226). (2003) 

King M-J, Chapman L, Mills W, Cinkotai K. & Banks J.  Presence of aberrant band 3 and glycophorin Dantu in a patient with hereditary elliptocytosis. Transfusion Medicine 13, Supplement 1, p31 abstract #26. (2003) 

Kumpel BM. Secretion of soluble HLA-G1 by syncytiotrophoblasts and cytotrophoblasts isolated from term placentae. Tissue antigens 2003;62:345.

Kumpel BM. Comparative staining of endothelial cells from term placental villi by four monoclonal antibodies using immunohistochemistry and flow cytometry. Placenta 2003;24:A.28.

Kumpel BM. Recent advances in the assessment of FMH by flow cytometry. Transfusion Medicine 2003;13 suppl 1:22.

Kumpel BM, Jackson DJ. Immunocytochemical analysis of CD41, CD61 and human platelet antigen 1a expression in human placenta. Transfusion Medicine 2003;13 suppl 1:36.

Layton M, Wilkes A, Kumpel B, King M-J, Banks J, Roper D and Regan F. Hydrops fetalis resulting from apparently insignificant levels of alloimmune anti-D. Br J Haematology (2003) vol. 121, Supplement 1, p44 (abstract #132).

Maley M, Rounding L, Babb R, Wells A, Poole J, Pickens F. Co-expression of weak and partial D antigens in a twin pregnancy. Transfusion Medicine 13 supp. 1, P1 (2003).

Needs ME, Banks J, Win N, Poole J, Reid M, Hue-Royd K. A case of anti-Hy in a sickle cell patient with an unusual Dombrock phenotype. Transfusion Medicine 13 supp. 1, P34 (2003).

Poole J. The WHO International Rare Donor Panel – an update and future considerations. Proceedings of VIII European Congress of the ISBT, O130 Istanbul – Turkey July 5-9 (2003).

Poole J. The D antigen: importance of weak D and partial D in donors, recipients and the obstetric population. Proceedings of the 3rd Croatian Congress on Haematology and Transfusion Medicine suppl. 3: 41-42 (2003).

Poole J, Morris K, Anderson J, Warke N, Melanaphy R, Jackson M. Drug induced autoimmune haemolytic anaemia in association with Mefloquine anti-malarial prophylaxis. Proceedings of VIII European Congress of the ISBT, P375 Istanbul–Turkey July 5-9 (2003).

Poole J, Warke N, Melanaphy R,  Murdock J, Anderson J, Jackson M and Morris K. Drug-Induced AIHA in Association with Mefloquine Antimalarial Prophylaxis. Transfusion Medicine 13 supp.1. O11 (2003) 

Prowse C, Kingdom SM, Beach B, King M-J, Goodrick J, Poole J. Anti-Mia causing haemolytic disease of the newborn in a British family. Transfusion Medicine 13 supp. 1, P24 (2003).

Reid M, Storry JR, Hue-Roye K, Powell V, Banks J, Poole J, Ahrens N, Salama A, Ma B-W, Lublin DM. SERF: A new high prevalence antigen in the Cromer blood group system. Transfusion 43 supp. S21-030D (2003).

Ridgwell K, Dixey J and Scott ML  The Production of Soluble Recombinant Kell Antigens and their use in Screening Human Sera for Anti-Kell Blood Group Antibodies. Transfusion Medicine 13 supp. 1. O10 (2003)

Scott ML The Future for Blood Transfusion Healthcare Science – The Role of BBTS. Transfusion Medicine 13 supp 1. S10 (2003)

Skinner LH, Webster S, Tai M, Wang MR, Poole J, Avent ND. Human erythroid RhCG is expressed as multiple isoforms. Transfusion Medicine 13 supp. 1, YS2 (2003).

Skinner LH, Webster S, Tail M, Head DJ, Wang MR, Poole J, Avent ND. RhCG is expressed in human red cells as multiple isoforms. Proceedings of VIII European Congress of the ISBT, P342 Istanbul – Turkey July 5-9 (2003).

Wilkes AM, Kumpel BM, Layton M, King M-J, Banks J, Roper D, Regan F, Poole J. Investigation of a fatal case of Rh D hydrops fetalis using quantitative and functional assays. Transfusion Medicine 2003;13 suppl 1:36.

Wester ES, Schneider K, Nilsson-Sojka B, Safwenberg J, Poole J, Storry JR, Olsson ML. Two novel Ko alleles in the swedish population. Transfusion Medicine 13 supp. 1, O12 (2003).

 

Produced for by the Intranet Design Team
This page was last updated on 14-May-09 .